Inari Medical
Irvine, US · Founded 2011 · Delaware corporation · 618 employees on LinkedIn · 4 known investors
Find your way into Inari Medical
Each arrow is one introduction. Sign up to fill in the first one.
Ask Juan-Pablo Mas to introduce you to Bill Hoffman
You →Juan-Pablo · together at Presidio Medical, Inc. →Bill
Sign up to find every way you can get introduced to Inari Medical
- Your email: who you already know at Inari Medical, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Inari Medical team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
Founders & leadership

Board

Investors · 4
How we know: Gilde Healthcare's portfolio page · funding news · fiercebiotech.com · Not right? Tell us
How we know: US Venture Partners's portfolio page · Not right? Tell us
How we know: the VCSheet dataset · Not right? Tell us
How we know: funding news · fiercebiotech.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$45.5M disclosed across 3 rounds · 2015–2018
▶$27MraisedApr 2018 · 20 investors · Other Health CareRule 506(b)
- Donald MilderDirector
- Robert RosenbluthExecutive Officer, Director
- William H. HoffmanExecutive Officer, Director
- Brian CoxDirector
- Kirk NielsenDirector
- Jonathan RootDirector
- Paul LubockDirector
- Offering amount
- $27M
- Amount sold
- $27M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.1MraisedDec 2015 · 5 investors · Other Health CareRule 506(b)
- Paul LubockDirector
- William H. HoffmanExecutive Officer, Director
- Kirk NielsenDirector
- Brian CoxDirector
- Donald MilderDirector
- Robert RosenbluthExecutive Officer, Director
- Jonathan RootDirector
- Offering amount
- $6.1M
- Amount sold
- $6.1M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$12.4MraisedJul 2015 · 24 investors · Other Health CareRule 506(b)
- Robert RosenbluthExecutive Officer, Director
- William H. HoffmanExecutive Officer, Director
- Brian CoxDirector
- Donald MilderDirector
- Paul LubockDirector
- Kirk NielsenDirector
- Jonathan RootDirector
- Offering amount
- $12.4M
- Amount sold
- $12.4M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Inari Medical.
In the news
Frequently asked questions
- What does Inari Medical do?
- Inari Medical develops mechanical thrombectomy devices for treating venous thromboembolism conditions, including pulmonary embolism, deep vein thrombosis, in-stent thrombosis, and arteriovenous fistula thrombosis. Its product portfolio includes the FlowTriever and ClotTriever systems, catheters, and blood return systems used by clinicians treating vascular blood clots.
- Who are Inari Medical's investors?
- Inari Medical's investors include Gilde Healthcare, US Venture Partners, Vensana Capital, Versant Ventures.
- How much funding has Inari Medical raised?
- Inari Medical has disclosed $45.5M raised across 3 rounds.
- Where is Inari Medical headquartered?
- Inari Medical is headquartered in Irvine, US.






